- Home
- / Active Biotech
Active Biotech
Stock Price
KR0.3
2024-10-29
Market Capitalization
KR224.4 M
2024-10-29
Active Biotech Summary
Company Summary
- Overview
- Active Biotech is a biotechnology company with a focus on neurodegenerative and inflammatory diseases and cancer. Its offering includes Naptumomab, a product for the treatment of solid tumors, Tasquinimod, a product for the treatment of multiple myeloma; and Laquinimod, a product for the treatment of eye disorders.
- Type
- Public
- Status
- Active
- Founded
- 1998
- HQ
- Lund, SE | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Hans Kolam, Chief Financial Officer
Michael Shalmi, Chairman of the Board
Elaine Sullivan, Board Member
Operating MetricsView all
Phase I Trials Products
2
FY, 2020
Phase II Trials Products
1
FY, 2020
Phase III Trials Products
1
FY, 2018
LocationsView all
2 locations detected
Lund HQ
Sweden
Scheelevägen 22
Lund, Skåne län
Sweden
Lund 724 7
Active Biotech Financials
Summary Financials
- Net income (Q1, 2026)
- (kr8.4M)
- Cash (Q1, 2026)
- kr53.3M
- EBIT (Q1, 2026)
- (kr8.6M)
- Enterprise value
- $161.0M